Malucchi S, Bava CI, Valentino P, Martire S, et al. In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting. J Neurol 2024 Sep 23. doi: 10.1007/s00415-024-12701.
PMID: 39313638